The Latest Breaking News from THC

The hospital operator is eying growth opportunities coming out of the Covid pandemic.

Hospital operator HCA Healthcare (HCA) could receive a boost in its profits due to its continuous efforts to bolster its portfolio. So, it could be wise to invest in the stock now. Let’s look at some of its key financial metrics….

With advancements in technology and increased demand for healthcare services, now may be the perfect time to invest in fundamentally strong medical stocks, HCA Healthcare (HCA), Fresenius SE & Co (FSNUY), and Tenet Healthcare (THC), which seem well-positioned to capitalize on the industry’s tailwinds. Read more….

A whale with a lot of money to spend has taken a noticeably bullish stance on Tenet Healthcare. Looking at options history for Tenet Healthcare (NYSE:THC) we detected 12 strange trades.

On Thursday, shares of Tenet Healthcare Corporation (NYSE: THC) experienced volatile short activity. After the activity, the stock price went down -7.10% to $52.56. The overall sentiment for THC has been Bearish.

Icanic Brands Company, Inc. (OTCQB: ICNAF) (CSE:ICAN) has signed a non-binding letter of interest to acquire DNA Organics, Inc. (“Lifted”).

Sipp Industries, Inc. (OTCPK:SIPC) has received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the “Aveina” brand.

RBC Capital Market reduced the target price for HCA Healthcare Inc (NYSE:HCA) from $291 to $267 (26.5% upside), noting the shares were well oversold on Friday (-22%) after a ~5.5% guide-down on known labor headwinds.  The analysts continue to view the labor backdrop as largely transitory and believe HCA management is well equipped to…

RBC Capital Markets views Tenet Healthcare Corp's (NYSE:THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds.  The analysts have raised the price target from $89 to $104 (41% upside) with an Outperform rating. Against an increasingly difficult labor backdrop characterized by high agency utilization, Tenet could hold…

Tenet Healthcare Corp's (NYSE:THC) Q1 FY22 adjusted EPS came in at $1.93, up from $1.30 a year ago and beating the management guidance of $0.92 - $1.15. Net operating revenue hit $4.74 billion, marginally down 0.75% Y/Y, beating the consensus of $4.71 billion. Management expected sales of $4.6 billion - $4.8 billion. Adjusted…

Tenet Healthcare (NYSE:THC) reported its Q1 earnings results on Wednesday, April 20, 2022 at 04:05 PM. Here's what investors need to know about the announcement.